Contact
Please use this form to send email to PR contact of this press release:
Celeris Therapeutics, Inc., pioneering AI-driven degrader discovery, appoints Nick DeHaan as VP, Head of Partnering
TO:
Christopher Trummer
Celeris Therapeutics
+43 660 3837648